| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |